Tislelizumab in Addition to BACE in Patients with NSCLC
Clinical trial NCT05058560 · COMPLETED
Trial details
- NCT number
- NCT05058560
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2025-02-04
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.